BackDaily Target 2X Long MRNA ETF Overview

Daily Target 2X Long MRNA ETF Goodwill

Daily Target 2X Long MRNA ETF's goodwill is $90M.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$89.86M
↓ 8.16% YoYΔ $-7.98M vs prior year quarter

Peer trimmed avg / median

Loading

Daily Target 2X Long MRNA ETF Goodwill History

Loading

Daily Target 2X Long MRNA ETF vs. peers: Goodwill Comparison

Loading

Daily Target 2X Long MRNA ETF Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Daily Target 2X Long MRNA ETF (MRNX) FAQ

Daily Target 2X Long MRNA ETF (MRNX) currently reports a goodwill of $90M as of June 2016. That compares with $98M in the prior-year period — down 8.2% year over year. Use the charts on this page to explore Daily Target 2X Long MRNA ETF's goodwill history and peer comparisons.

Daily Target 2X Long MRNA ETF's goodwill decreased from $98M to $90M — a 8.2% year-over-year decrease (period ending June 2016). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Daily Target 2X Long MRNA ETF reported $90M in goodwill as of June 2016. That compares with $98M in the prior-year period — down 8.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current goodwill of $90M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Daily Target 2X Long MRNA ETF, and consider following MRNX for alerts when major investors trade the stock.